Caplin Point Laboratories edges higher after its arm enters into strategic partnership with JAMP Pharma Group

18 Jan 2021 Evaluate

Caplin Point Laboratories is currently trading at Rs. 487.50, up by 0.50 points or 0.10% from its previous closing of Rs. 487.00 on the BSE.

The scrip opened at Rs. 488.00 and has touched a high and low of Rs. 503.00 and Rs. 481.80 respectively. So far 12156 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 686.00 on 07-Aug-2020 and a 52 week low of Rs. 180.00 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 504.95 and Rs. 464.00 respectively. The current market cap of the company is Rs. 3675.86 crore.

The promoters holding in the company stood at 69.03%, while Institutions and Non-Institutions held 2.80% and 28.17% respectively.

Caplin Point Laboratories’ wholly owned subsidiary company -- Caplin Steriles has entered into a strategic partnership with JAMP Pharma Group for six injectable products to be filed shortly in Canada. Some of these products have already been filed by Caplin Steriles in the USA.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1776.75 -36.05 (-1.99%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×